Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001558370-21-005110
Filing Date
2021-04-28
Accepted
2021-04-28 17:04:59
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A tmb-20210428xdefa14a.htm DEFA14A 27445
2 GRAPHIC tmb-20210428xdefa14a002.jpg GRAPHIC 73582
3 GRAPHIC tmb-20210428xdefa14a001.jpg GRAPHIC 119433
  Complete submission text file 0001558370-21-005110.txt   294410
Mailing Address 535 BOYLSTON STREET BOSTON MA 02116
Business Address 535 BOYLSTON STREET BOSTON MA 02116 6095104718
Aprea Therapeutics, Inc. (Filer) CIK: 0001781983 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-39069 | Film No.: 21865238
SIC: 2834 Pharmaceutical Preparations